Proc Natl Acad Sci USA 1978;75:197983 Altikat S, Ciftci M, Bykokuroglu ME
If considering any oral GLP-1 product, verify the source, confirm pharmacy licensure, and understand whether you are receiving an FDA-approved product or a compounded preparation
Proven Results and Success Stories Join a community of clients who have achieved incredible, lasting weight loss transformations through our evidence-based programs, demonstrating our commitment to real, sustainable results
If you suspect you are experiencing side effects from your medication, report them to the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk)
Y., Wewer Albrechtsen, N
References (this section): Eli Lilly: notes GI side effects commonly reported and often during dose escalation (Phase 2 summary) NEJM (2023): safety/adverse events in Phase 2 publication Is retatrutide FDA approved